{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T19:46:15Z","timestamp":1788378375142,"version":"build-2803163510"},"reference-count":147,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373932"],"award-info":[{"award-number":["82373932"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003995","name":"Natural Science Foundation of Anhui Province","doi-asserted-by":"crossref","award":["2208085MH203"],"award-info":[{"award-number":["2208085MH203"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003995","name":"Natural Science Foundation of Anhui Province","doi-asserted-by":"crossref","award":["2408085QH242"],"award-info":[{"award-number":["2408085QH242"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003995","name":"Natural Science Foundation of Anhui Province","doi-asserted-by":"crossref","award":["2508085J050"],"award-info":[{"award-number":["2508085J050"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Anhui Outstanding Young Teachers Cultivation Program","award":["YQZD2023023"],"award-info":[{"award-number":["YQZD2023023"]}]},{"name":"Anhui Province University Outstanding Youth Research Project","award":["2024AH020006"],"award-info":[{"award-number":["2024AH020006"]}]},{"name":"Anhui Medical University Youth Shuangpei Program","award":["2024"],"award-info":[{"award-number":["2024"]}]},{"name":"Anhui Provincial Health Commission Scientific Research Project","award":["AHWJ2024Aa30231"],"award-info":[{"award-number":["AHWJ2024Aa30231"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Prod. Bioprospect."],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Liver disease is a serious threat to human health, so its prevention and treatment have been the focus of medical research. In the past few years, natural products have proved to be promising and valuable in the treatment of liver diseases. The bioactive substance paeonol, extracted from the root bark of peony (Paeonia lactiflora) of the buttercup family, is a promising drug candidate because of its low toxicity and multifaceted pharmacological properties. This review comprehensively explored the therapeutic potential of paeonol in different liver pathologies as well as the regulatory mechanisms. Despite its promising potential, the poor solubility and rapid metabolism of paeonol hindered its clinical translation. To improve bioavailability and liver targeting, we highlighted the potential of paeonol as a next-generation therapy for liver diseases by integrating preclinical evidence and technological advances, while exploring key avenues for future research, such as metabolic regulation and smart nanocarrier design.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1007\/s13659-025-00554-3","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T23:05:41Z","timestamp":1767654341000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Functional roles and regulatory mechanisms of paeonol in the treatment of liver disease"],"prefix":"10.1007","volume":"16","author":[{"given":"Min","family":"Shu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengzhou","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"key":"554_CR1","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jhep.2019.03.004","volume":"71","author":"J Xiao","year":"2019","unstructured":"Xiao J, Wang F, Wong NK, He J, Zhang R, Sun R, et al. Global liver disease burdens and research trends: analysis from a Chinese perspective. J Hepatol. 2019;71:212\u201321. https:\/\/doi.org\/10.1016\/j.jhep.2019.03.004.","journal-title":"J Hepatol"},{"key":"554_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02072-z","volume":"10","author":"C Gan","year":"2025","unstructured":"Gan C, Yuan Y, Shen H, Gao J, Kong X, Che Z, et al. Liver diseases: epidemiology, causes, trends and predictions. Signal Transduct Target Ther. 2025;10:33. https:\/\/doi.org\/10.1038\/s41392-024-02072-z.","journal-title":"Signal Transduct Target Ther"},{"key":"554_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"554_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/nu10010009","author":"C Mandato","year":"2017","unstructured":"Mandato C, Di Nuzzi A, Vajro P. Nutrition and liver disease. Nutrients. 2017. https:\/\/doi.org\/10.3390\/nu10010009.","journal-title":"Nutrients"},{"key":"554_CR5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41575-018-0099-1","volume":"16","author":"JS Bajaj","year":"2019","unstructured":"Bajaj JS. Alcohol, liver disease and the gut microbiota. Nat Rev Gastroenterol Hepatol. 2019;16:235\u201346. https:\/\/doi.org\/10.1038\/s41575-018-0099-1.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"554_CR6","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1002\/ptr.6472","volume":"33","author":"G Chen","year":"2019","unstructured":"Chen G, Jia P, Yin ZY, Kong SZ, Xiang ZB, Zheng XX. Paeonol ameliorates monosodium urate-induced arthritis in rats through inhibiting nuclear factor-\u03baB-mediated proinflammatory cytokine production. Phytother Res. 2019;33:2971\u20138. https:\/\/doi.org\/10.1002\/ptr.6472.","journal-title":"Phytother Res"},{"key":"554_CR7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.biochi.2018.09.004","volume":"156","author":"J Li","year":"2019","unstructured":"Li J, Li Y, Pan S, Zhang L, He L, Niu Y. Paeonol attenuates ligation-induced periodontitis in rats by inhibiting osteoclastogenesis via regulating Nrf2\/NF-\u03baB\/NFATc1 signaling pathway. Biochimie. 2019;156:129\u201337. https:\/\/doi.org\/10.1016\/j.biochi.2018.09.004.","journal-title":"Biochimie"},{"key":"554_CR8","doi-asserted-by":"publisher","first-page":"151455","DOI":"10.1016\/j.acthis.2019.151455","volume":"122","author":"J Zhou","year":"2020","unstructured":"Zhou J, Liu Q, Qian R, Liu S, Hu W, Liu Z. Paeonol antagonizes oncogenesis of osteosarcoma by inhibiting the function of TLR4\/MAPK\/NF-\u03baB pathway. Acta Histochem. 2020;122:151455. https:\/\/doi.org\/10.1016\/j.acthis.2019.151455.","journal-title":"Acta Histochem"},{"key":"554_CR9","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1021\/acs.chemrestox.9b00093","volume":"33","author":"S Thabassum Akhtar Iqbal","year":"2020","unstructured":"Thabassum Akhtar Iqbal S, Tirupathi Pichiah PB, Raja S, Arunachalam S. Paeonol reverses Adriamycin induced cardiac pathological remodeling through Notch1 signaling reactivation in H9c2 cells and adult zebrafish heart. Chem Res Toxicol. 2020;33:312\u201323. https:\/\/doi.org\/10.1021\/acs.chemrestox.9b00093.","journal-title":"Chem Res Toxicol"},{"key":"554_CR10","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1080\/13880209.2022.2040543","volume":"60","author":"X Chen","year":"2022","unstructured":"Chen X, Zhang Z, Zhang X, Jia Z, Liu J, Chen X, et al. Paeonol attenuates heart failure induced by transverse aortic constriction via ERK1\/2 signalling. Pharm Biol. 2022;60:562\u20139. https:\/\/doi.org\/10.1080\/13880209.2022.2040543.","journal-title":"Pharm Biol"},{"key":"554_CR11","doi-asserted-by":"publisher","first-page":"536","DOI":"10.4062\/biomolther.2015.191","volume":"24","author":"Y Chen","year":"2016","unstructured":"Chen Y, Liu Z, Zhou F, Zhao H, Yang Q, Li H, et al. Evaluating pharmacological effects of two major components of Shuangdan oral liquid: role of Danshensu and Paeonol in diabetic nephropathy rat. Biomol Ther. 2016;24:536\u201342. https:\/\/doi.org\/10.4062\/biomolther.2015.191.","journal-title":"Biomol Ther"},{"key":"554_CR12","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1080\/08923973.2019.1613427","volume":"41","author":"S Wu","year":"2019","unstructured":"Wu S, Liu L, Yang S, Kuang G, Yin X, Wang Y, et al. Paeonol alleviates CCl(4)-induced liver fibrosis through suppression of hepatic stellate cells activation via inhibiting the TGF-\u03b2\/Smad3 signaling. Immunopharmacol Immunotoxicol. 2019;41:438\u201345. https:\/\/doi.org\/10.1080\/08923973.2019.1613427.","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"554_CR13","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2021.12419","author":"S Xu","year":"2021","unstructured":"Xu S, Xu J, Hao T, Yan Y, Zhang S, Li A, et al. Paeonol alleviates lipopolysaccharide-induced hepatocytes injury through alteration of mitochondrial function and NF-\u03baB translocation. Mol Med Rep. 2021. https:\/\/doi.org\/10.3892\/mmr.2021.12419.","journal-title":"Mol Med Rep"},{"key":"554_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.131959","volume":"269","author":"Z Wang","year":"2024","unstructured":"Wang Z, Feng B, Gao Q, Wang Y, Yang Y, Luo B, et al. A prediction method of interaction based on Bilinear Attention Networks for designing polyphenol-protein complexes delivery systems. Int J Biol Macromol. 2024;269:131959. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.131959.","journal-title":"Int J Biol Macromol"},{"key":"554_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.126962","volume":"253","author":"X Min","year":"2023","unstructured":"Min X, Lu L, Xu X, Wen Y, Zheng X. Investigation on the inhibition mechanism and binding behavior of paeonol to tyrosinase and its anti-browning property by multi-spectroscopic and molecular docking methods. Int J Biol Macromol. 2023;253:126962. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.126962.","journal-title":"Int J Biol Macromol"},{"key":"554_CR16","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/1098617","volume":"2018","author":"L Lu","year":"2018","unstructured":"Lu L, Qin Y, Chen C, Guo X. Beneficial effects exerted by paeonol in the management of atherosclerosis. Oxid Med Cell Longev. 2018;2018:1098617. https:\/\/doi.org\/10.1155\/2018\/1098617.","journal-title":"Oxid Med Cell Longev"},{"key":"554_CR17","doi-asserted-by":"publisher","first-page":"4882","DOI":"10.3390\/ijms11124882","volume":"11","author":"X Chen","year":"2010","unstructured":"Chen X, Lu Y, Du S, Xu B, Wang S, Zhai Y, et al. In situ and in vivo study of nasal absorption of paeonol in rats. Int J Mol Sci. 2010;11:4882\u201390. https:\/\/doi.org\/10.3390\/ijms11124882.","journal-title":"Int J Mol Sci"},{"key":"554_CR18","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1016\/j.cgh.2019.07.060","volume":"18","author":"AM Moon","year":"2020","unstructured":"Moon AM, Singal AG, Tapper EB. Contemporary epidemiology of chronic liver disease and cirrhosis. Clin Gastroenterol Hepatol. 2020;18:2650\u201366. https:\/\/doi.org\/10.1016\/j.cgh.2019.07.060.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"554_CR19","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/jlb.3mr0121-277r","volume":"110","author":"YA Ni","year":"2021","unstructured":"Ni YA, Chen H, Nie H, Zheng B, Gong Q. HMGB1: an overview of its roles in the pathogenesis of liver disease. J Leukoc Biol. 2021;110:987\u201398. https:\/\/doi.org\/10.1002\/jlb.3mr0121-277r.","journal-title":"J Leukoc Biol"},{"key":"554_CR20","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","volume":"79","author":"H Devarbhavi","year":"2023","unstructured":"Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. J Hepatol. 2023;79:516\u201337. https:\/\/doi.org\/10.1016\/j.jhep.2023.03.017.","journal-title":"J Hepatol"},{"key":"554_CR21","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.ads9470","volume":"17","author":"S Sharma","year":"2025","unstructured":"Sharma S, Prathigudupu V, Cable C, Serrano LR, Nerella S, Chen A, et al. Resolving fibrosis by stimulating HSC-dependent extracellular matrix degradation. Sci Transl Med. 2025;17:eads9470. https:\/\/doi.org\/10.1126\/scitranslmed.ads9470.","journal-title":"Sci Transl Med"},{"key":"554_CR22","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.3748\/wjg.v24.i16.1679","volume":"24","author":"E Hern\u00e1ndez-Aquino","year":"2018","unstructured":"Hern\u00e1ndez-Aquino E, Muriel P. Beneficial effects of naringenin in liver diseases: molecular mechanisms. World J Gastroenterol. 2018;24:1679\u2013707. https:\/\/doi.org\/10.3748\/wjg.v24.i16.1679.","journal-title":"World J Gastroenterol"},{"key":"554_CR23","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1007\/s00204-020-02885-1","volume":"94","author":"M Garcia-Cortes","year":"2020","unstructured":"Garcia-Cortes M, Robles-Diaz M, Stephens C, Ortega-Alonso A, Lucena MI, Andrade RJ. Drug induced liver injury: an update. Arch Toxicol. 2020;94:3381\u2013407. https:\/\/doi.org\/10.1007\/s00204-020-02885-1.","journal-title":"Arch Toxicol"},{"key":"554_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0105-0","volume":"5","author":"RJ Andrade","year":"2019","unstructured":"Andrade RJ, Chalasani N, Bj\u00f6rnsson ES, Suzuki A, Kullak-Ublick GA, Watkins PB, et al. Drug-induced liver injury. Nat Rev Dis Primers. 2019;5:58. https:\/\/doi.org\/10.1038\/s41572-019-0105-0.","journal-title":"Nat Rev Dis Primers"},{"key":"554_CR25","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1053\/j.gastro.2019.02.002","volume":"156","author":"T Shen","year":"2019","unstructured":"Shen T, Liu Y, Shang J, Xie Q, Li J, Yan M, et al. Incidence and etiology of drug-induced liver injury in mainland China. Gastroenterology. 2019;156:2230-2241.e11. https:\/\/doi.org\/10.1053\/j.gastro.2019.02.002.","journal-title":"Gastroenterology"},{"key":"554_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/liv.13931","volume":"39","author":"A Hassan","year":"2019","unstructured":"Hassan A, Fontana RJ. The diagnosis and management of idiosyncratic drug-induced liver injury. Liver Int. 2019;39:31\u201341. https:\/\/doi.org\/10.1111\/liv.13931.","journal-title":"Liver Int"},{"key":"554_CR27","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1097\/hep.0000000000001052","volume":"82","author":"ES Bjornsson","year":"2025","unstructured":"Bjornsson ES, Devarbhavi HC. Drug-induced cholestatic liver diseases. Hepatology. 2025;82:996\u20131015. https:\/\/doi.org\/10.1097\/hep.0000000000001052.","journal-title":"Hepatology"},{"key":"554_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cbi.2015.11.025","volume":"244","author":"J Wu","year":"2016","unstructured":"Wu J, Xue X, Zhang B, Jiang W, Cao H, Wang R, et al. The protective effects of paeonol against epirubicin-induced hepatotoxicity in 4T1-tumor bearing mice via inhibition of the PI3K\/Akt\/NF-kB pathway. Chem Biol Interact. 2016;244:1\u20138. https:\/\/doi.org\/10.1016\/j.cbi.2015.11.025.","journal-title":"Chem Biol Interact"},{"key":"554_CR29","doi-asserted-by":"publisher","first-page":"253","DOI":"10.5582\/bst.2019.01105","volume":"13","author":"X Jing","year":"2019","unstructured":"Jing X, Sun C, Chen H, Sun J, Zhang Y, Wu J. Protection of paeonol against epirubicin-induced hepatotoxicity: a metabolomic study. Biosci Trends. 2019;13:253\u201360. https:\/\/doi.org\/10.5582\/bst.2019.01105.","journal-title":"Biosci Trends"},{"key":"554_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2024.117475","volume":"289","author":"L Sun","year":"2025","unstructured":"Sun L, He S, Chen J, Su A, Mao Q, Zhang W, et al. Hepatic injury and metabolic perturbations in mice exposed to perfluorodecanoic acid revealed by metabolomics and lipidomics. Ecotoxicol Environ Saf. 2025;289:117475. https:\/\/doi.org\/10.1016\/j.ecoenv.2024.117475.","journal-title":"Ecotoxicol Environ Saf"},{"key":"554_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102569","volume":"59","author":"A Abulikemu","year":"2023","unstructured":"Abulikemu A, Zhao X, Xu H, Li Y, Ma R, Yao Q, et al. Silica nanoparticles aggravated the metabolic associated fatty liver disease through disturbed amino acid and lipid metabolisms-mediated oxidative stress. Redox Biol. 2023;59:102569. https:\/\/doi.org\/10.1016\/j.redox.2022.102569.","journal-title":"Redox Biol"},{"key":"554_CR32","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41584-022-00883-4","volume":"19","author":"V Di Martino","year":"2023","unstructured":"Di Martino V, Verhoeven DW, Verhoeven F, Aubin F, Avouac J, Vuitton L, et al. Busting the myth of methotrexate chronic hepatotoxicity. Nat Rev Rheumatol. 2023;19:96\u2013110. https:\/\/doi.org\/10.1038\/s41584-022-00883-4.","journal-title":"Nat Rev Rheumatol"},{"key":"554_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103161","volume":"82","author":"G Sandhu","year":"2025","unstructured":"Sandhu G, Adattini J, Armstrong Gordon E, O\u2019Neill N, Bagnis C, Boddy AV, et al. Integrating international consensus guidelines for anticancer drug dosing in kidney dysfunction (ADDIKD) into everyday practice. EClinicalMedicine. 2025;82:103161. https:\/\/doi.org\/10.1016\/j.eclinm.2025.103161.","journal-title":"EClinicalMedicine"},{"key":"554_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ph15101296","author":"MA Morsy","year":"2022","unstructured":"Morsy MA, Abdel-Latif R, Hafez S, Kandeel M, Abdel-Gaber SA. Paeonol protects against methotrexate hepatotoxicity by repressing oxidative stress, inflammation, and apoptosis-the role of drug efflux transporters. Pharmaceuticals. 2022. https:\/\/doi.org\/10.3390\/ph15101296.","journal-title":"Pharmaceuticals"},{"key":"554_CR35","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.taap.2005.03.027","volume":"207","author":"W Vaalburg","year":"2005","unstructured":"Vaalburg W, Hendrikse NH, Elsinga PH, Bart J, van Waarde A. P-glycoprotein activity and biological response. Toxicol Appl Pharmacol. 2005;207:257\u201360. https:\/\/doi.org\/10.1016\/j.taap.2005.03.027.","journal-title":"Toxicol Appl Pharmacol"},{"key":"554_CR36","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/s0168-8278(03)00410-0","volume":"39","author":"H Kojima","year":"2003","unstructured":"Kojima H, Nies AT, K\u00f6nig J, Hagmann W, Spring H, Uemura M, et al. Changes in the expression and localization of hepatocellular transporters and radixin in primary biliary cirrhosis. J Hepatol. 2003;39:693\u2013702. https:\/\/doi.org\/10.1016\/s0168-8278(03)00410-0.","journal-title":"J Hepatol"},{"key":"554_CR37","doi-asserted-by":"publisher","first-page":"3368","DOI":"10.1111\/j.1572-0241.2001.05339.x","volume":"96","author":"J Shoda","year":"2001","unstructured":"Shoda J, Kano M, Oda K, Kamiya J, Nimura Y, Suzuki H, et al. The expression levels of plasma membrane transporters in the cholestatic liver of patients undergoing biliary drainage and their association with the impairment of biliary secretory function. Am J Gastroenterol. 2001;96:3368\u201378. https:\/\/doi.org\/10.1111\/j.1572-0241.2001.05339.x.","journal-title":"Am J Gastroenterol"},{"key":"554_CR38","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/hep.510310319","volume":"31","author":"CC Paulusma","year":"2000","unstructured":"Paulusma CC, Kothe MJ, Bakker CT, Bosma PJ, van Bokhoven I, van Marle J, et al. Zonal down-regulation and redistribution of the multidrug resistance protein 2 during bile duct ligation in rat liver. Hepatology. 2000;31:684\u201393. https:\/\/doi.org\/10.1002\/hep.510310319.","journal-title":"Hepatology"},{"key":"554_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001338","volume":"9","author":"P Recknagel","year":"2012","unstructured":"Recknagel P, Gonnert FA, Westermann M, Lambeck S, Lupp A, Rudiger A, et al. Liver dysfunction and phosphatidylinositol-3-kinase signalling in early sepsis: experimental studies in rodent models of peritonitis. PLoS Med. 2012;9:e1001338. https:\/\/doi.org\/10.1371\/journal.pmed.1001338.","journal-title":"PLoS Med"},{"key":"554_CR40","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1161\/circresaha.117.311401","volume":"122","author":"SJ Forrester","year":"2018","unstructured":"Forrester SJ, Kikuchi DS, Hernandes MS, Xu Q, Griendling KK. Reactive oxygen species in metabolic and inflammatory signaling. Circ Res. 2018;122:877\u2013902. https:\/\/doi.org\/10.1161\/circresaha.117.311401.","journal-title":"Circ Res"},{"key":"554_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14080958","author":"M Guerra-Andr\u00e9s","year":"2025","unstructured":"Guerra-Andr\u00e9s M, Mart\u00ednez-Rojo I, Piedra-Mac\u00edas A, Lavado-Fern\u00e1ndez E, Garc\u00eda-Macia M, F Fern\u00e1ndez \u00c1. Oxidative Stress in the regulation of autosis-related proteins. Antioxidants. 2025. https:\/\/doi.org\/10.3390\/antiox14080958.","journal-title":"Antioxidants"},{"key":"554_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14080944","author":"KJ Dery","year":"2025","unstructured":"Dery KJ, Chiu R, Kasargod A, Kupiec-Weglinski JW. Feedback loops shape oxidative and immune interactions in hepatic ischemia-reperfusion injury. Antioxidants. 2025. https:\/\/doi.org\/10.3390\/antiox14080944.","journal-title":"Antioxidants"},{"key":"554_CR43","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1083\/jcb.201708007","volume":"217","author":"Y Wang","year":"2018","unstructured":"Wang Y, Branicky R, No\u00eb A, Hekimi S. Superoxide dismutases: dual roles in controlling ROS damage and regulating ROS signaling. J Cell Biol. 2018;217:1915\u201328. https:\/\/doi.org\/10.1083\/jcb.201708007.","journal-title":"J Cell Biol"},{"key":"554_CR44","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jconrel.2022.02.033","volume":"344","author":"K Kwon","year":"2022","unstructured":"Kwon K, Jung J, Sahu A, Tae G. Nanoreactor for cascade reaction between SOD and CAT and its tissue regeneration effect. J Controlled Release. 2022;344:160\u201372. https:\/\/doi.org\/10.1016\/j.jconrel.2022.02.033.","journal-title":"J Controlled Release"},{"key":"554_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.108432","volume":"160","author":"A El-Aal","year":"2025","unstructured":"El-Aal A, Jayakumar FA, Tan KO, Lahiri C, Chung FF, Reginald K. Whiteleg shrimp-derived cryptides induce mitochondrial-mediated cytotoxicity in human breast cancer. Bioorg Chem. 2025;160:108432. https:\/\/doi.org\/10.1016\/j.bioorg.2025.108432.","journal-title":"Bioorg Chem"},{"key":"554_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/foods14040604","author":"L Zhou","year":"2025","unstructured":"Zhou L, Gao X, Huang Q, Chen Z, Zhang Y, Zhu F, et al. Discovery and characterization of a distinctive Theaflavin-3-Gallate isomer from Camellia ptilophylla with potent anticancer properties against Human Colorectal Carcinoma cells. 2025. Foods. https:\/\/doi.org\/10.3390\/foods14040604."},{"key":"554_CR47","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1080\/109374001301419737","volume":"4","author":"AW Abu-Qare","year":"2001","unstructured":"Abu-Qare AW, Abou-Donia MB. Biomarkers of apoptosis: release of cytochrome c, activation of caspase-3, induction of 8-hydroxy-2\u2032-deoxyguanosine, increased 3-nitrotyrosine, and alteration of p53 gene. J Toxicol Environ Health Part B. 2001;4:313\u201332. https:\/\/doi.org\/10.1080\/109374001301419737.","journal-title":"J Toxicol Environ Health Part B"},{"key":"554_CR48","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.phrs.2018.12.014","volume":"141","author":"K Bavarsad","year":"2019","unstructured":"Bavarsad K, Riahi MM, Saadat S, Barreto G, Atkin SL, Sahebkar A. Protective effects of curcumin against ischemia-reperfusion injury in the liver. Pharmacol Res. 2019;141:53\u201362. https:\/\/doi.org\/10.1016\/j.phrs.2018.12.014.","journal-title":"Pharmacol Res"},{"key":"554_CR49","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/ajt.16219","volume":"21","author":"T Ito","year":"2021","unstructured":"Ito T, Naini BV, Markovic D, Aziz A, Younan S, Lu M, et al. Ischemia-reperfusion injury and its relationship with early allograft dysfunction in liver transplant patients. Am J Transplant. 2021;21:614\u201325. https:\/\/doi.org\/10.1111\/ajt.16219.","journal-title":"Am J Transplant"},{"key":"554_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.236","volume":"8","author":"M Ge","year":"2017","unstructured":"Ge M, Yao W, Yuan D, Zhou S, Chen X, Zhang Y, et al. Brg1-mediated Nrf2\/HO-1 pathway activation alleviates hepatic ischemia-reperfusion injury. Cell death disease. 2017;8:e2841. https:\/\/doi.org\/10.1038\/cddis.2017.236.","journal-title":"Cell death disease"},{"key":"554_CR51","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.jhep.2017.08.010","volume":"67","author":"K Nakamura","year":"2017","unstructured":"Nakamura K, Zhang M, Kageyama S, Ke B, Fujii T, Sosa RA, et al. Macrophage heme oxygenase-1-SIRT1-p53 axis regulates sterile inflammation in liver ischemia-reperfusion injury. J Hepatol. 2017;67:1232\u201342. https:\/\/doi.org\/10.1016\/j.jhep.2017.08.010.","journal-title":"J Hepatol"},{"key":"554_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01905-2","volume":"22","author":"Q Wang","year":"2024","unstructured":"Wang Q, Li S, Wu W, Zhou W, Yan K, Liu Z, et al. RNF13 protects neurons against ischemia-reperfusion injury via stabilizing p62-mediated Nrf2\/HO-1 signaling pathway. Cell Commun Signal. 2024;22:535. https:\/\/doi.org\/10.1186\/s12964-024-01905-2.","journal-title":"Cell Commun Signal"},{"key":"554_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2024.e00444","volume":"21","author":"M Sun","year":"2024","unstructured":"Sun M, Chen J, Liu F, Li P, Lu J, Ge S, et al. Butylphthalide inhibits ferroptosis and ameliorates cerebral ischaemia-reperfusion injury in rats by activating the Nrf2\/HO-1 signalling pathway. Neurotherapeutics. 2024;21:e00444. https:\/\/doi.org\/10.1016\/j.neurot.2024.e00444.","journal-title":"Neurotherapeutics"},{"key":"554_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11091687","author":"MA Morsy","year":"2022","unstructured":"Morsy MA, Ibrahim YF, Abdel Hafez SMN, Zenhom NM, Nair AB, Venugopala KN, et al. Paeonol attenuates hepatic ischemia\/reperfusion injury by modulating the Nrf2\/HO-1 and TLR4\/MYD88\/NF-\u03baB signaling pathways. Antioxidants. 2022. https:\/\/doi.org\/10.3390\/antiox11091687.","journal-title":"Antioxidants"},{"key":"554_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222413219","author":"B Filipovic","year":"2021","unstructured":"Filipovic B, Lukic S, Mijac D, Marjanovic-Haljilji M, Vojnovic M, Bogdanovic J, et al. The new therapeutic approaches in the treatment of non-alcoholic fatty liver disease. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms222413219.","journal-title":"Int J Mol Sci"},{"key":"554_CR56","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41575-018-0011-z","volume":"15","author":"A Tripathi","year":"2018","unstructured":"Tripathi A, Debelius J, Brenner DA, Karin M, Loomba R, Schnabl B, et al. The gut-liver axis and the intersection with the microbiome. Nat Rev Gastroenterol Hepatol. 2018;15:397\u2013411. https:\/\/doi.org\/10.1038\/s41575-018-0011-z.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"554_CR57","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.molmed.2007.12.005","volume":"14","author":"M Vidali","year":"2008","unstructured":"Vidali M, Stewart SF. Interplay between oxidative stress and immunity in the progression of alcohol-mediated liver injury. Trends Mol Med. 2008;14:63\u201371. https:\/\/doi.org\/10.1016\/j.molmed.2007.12.005. (Albano E).","journal-title":"Trends Mol Med"},{"key":"554_CR58","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jep.2009.12.034","volume":"128","author":"S Hu","year":"2010","unstructured":"Hu S, Shen G, Zhao W, Wang F, Jiang X, Huang D. Paeonol, the main active principles of Paeonia moutan, ameliorates alcoholic steatohepatitis in mice. J Ethnopharmacol. 2010;128:100\u20136. https:\/\/doi.org\/10.1016\/j.jep.2009.12.034.","journal-title":"J Ethnopharmacol"},{"key":"554_CR59","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.etap.2018.04.016","volume":"60","author":"X Sun","year":"2018","unstructured":"Sun X, Wang P, Yao LP, Wang W, Gao YM, Zhang J, et al. Paeonol alleviated acute alcohol-induced liver injury via SIRT1\/Nrf2\/NF-\u03baB signaling pathway. Environ Toxicol Pharmacol. 2018;60:110\u20137. https:\/\/doi.org\/10.1016\/j.etap.2018.04.016.","journal-title":"Environ Toxicol Pharmacol"},{"key":"554_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102745","volume":"63","author":"HR Li","year":"2023","unstructured":"Li HR, Liu Q, Zhu CL, Sun XY, Sun CY, Yu CM, et al. \u0392-nicotinamide mononucleotide activates NAD+\/SIRT1 pathway and attenuates inflammatory and oxidative responses in the hippocampus regions of septic mice. Redox Biol. 2023;63:102745. https:\/\/doi.org\/10.1016\/j.redox.2023.102745.","journal-title":"Redox Biol"},{"key":"554_CR61","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jhep.2021.11.026","volume":"76","author":"K Kadono","year":"2022","unstructured":"Kadono K, Kageyama S, Nakamura K, Hirao H, Ito T, Kojima H, et al. Myeloid Ikaros-SIRT1 signaling axis regulates hepatic inflammation and pyroptosis in ischemia-stressed mouse and human liver. J Hepatol. 2022;76:896\u2013909. https:\/\/doi.org\/10.1016\/j.jhep.2021.11.026.","journal-title":"J Hepatol"},{"key":"554_CR62","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jhep.2018.02.005","volume":"69","author":"YE Cho","year":"2018","unstructured":"Cho YE, Yu LR, Abdelmegeed MA, Yoo SH, Song BJ. Apoptosis of enterocytes and nitration of junctional complex proteins promote alcohol-induced gut leakiness and liver injury. J Hepatol. 2018;69:142\u201353. https:\/\/doi.org\/10.1016\/j.jhep.2018.02.005.","journal-title":"J Hepatol"},{"key":"554_CR63","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.3390\/biom5032140","volume":"5","author":"JL Groebner","year":"2015","unstructured":"Groebner JL, Tuma PL. The altered hepatic tubulin code in alcoholic liver disease. Biomolecules. 2015;5:2140\u201359. https:\/\/doi.org\/10.3390\/biom5032140.","journal-title":"Biomolecules"},{"key":"554_CR64","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41586-019-1742-x","volume":"575","author":"Y Duan","year":"2019","unstructured":"Duan Y, Llorente C, Lang S, Brandl K, Chu H, Jiang L, et al. Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease. Nature. 2019;575:505\u201311. https:\/\/doi.org\/10.1038\/s41586-019-1742-x.","journal-title":"Nature"},{"key":"554_CR65","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.chom.2024.06.008","volume":"32","author":"H Shen","year":"2024","unstructured":"Shen H, Zhou L, Zhang H, Yang Y, Jiang L, Wu D, et al. Dietary fiber alleviates alcoholic liver injury via Bacteroides acidifaciens and subsequent ammonia detoxification. Cell host microbe. 2024;32:1331-1346.e6. https:\/\/doi.org\/10.1016\/j.chom.2024.06.008.","journal-title":"Cell host microbe"},{"key":"554_CR66","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3350\/cmh.2017.0067","volume":"24","author":"AM Cassard","year":"2018","unstructured":"Cassard AM, Ciocan D. Microbiota, a key player in alcoholic liver disease. Clin Mol Hepatol. 2018;24:100\u20137. https:\/\/doi.org\/10.3350\/cmh.2017.0067.","journal-title":"Clin Mol Hepatol"},{"key":"554_CR67","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/jlb.3ma0120-325rr","volume":"108","author":"J Wu","year":"2020","unstructured":"Wu J, Wu D, Ma K, Wang T, Shi G, Shao J, et al. Paeonol ameliorates murine alcohol liver disease via mycobiota-mediated Dectin-1\/IL-1\u03b2 signaling pathway. J Leukoc Biol. 2020;108:199\u2013214. https:\/\/doi.org\/10.1002\/jlb.3ma0120-325rr.","journal-title":"J Leukoc Biol"},{"key":"554_CR68","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1016\/j.celrep.2015.10.058","volume":"13","author":"L Seifert","year":"2015","unstructured":"Seifert L, Deutsch M, Alothman S, Alqunaibit D, Werba G, Pansari M, et al. Dectin-1 regulates hepatic fibrosis and hepatocarcinogenesis by suppressing TLR4 signaling pathways. Cell Rep. 2015;13:1909\u201321. https:\/\/doi.org\/10.1016\/j.celrep.2015.10.058.","journal-title":"Cell Rep"},{"key":"554_CR69","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/hep.0000000000000323","volume":"77","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, Abdelmalek MF, Caldwell S, Barb D, et al. Aasld practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023;77:1797\u2013835. https:\/\/doi.org\/10.1097\/hep.0000000000000323.","journal-title":"Hepatology"},{"key":"554_CR70","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41575-022-00688-6","volume":"20","author":"DQ Huang","year":"2023","unstructured":"Huang DQ, Mathurin P, Cortez-Pinto H, Loomba R. Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors. Nat Rev Gastroenterol Hepatol. 2023;20:37\u201349. https:\/\/doi.org\/10.1038\/s41575-022-00688-6.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"554_CR71","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/s41575-023-00822-y","volume":"20","author":"LA D\u00edaz","year":"2023","unstructured":"D\u00edaz LA, Arab JP, Louvet A, Bataller R, Arrese M. The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 2023;20:764\u201383. https:\/\/doi.org\/10.1038\/s41575-023-00822-y.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"554_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118147","volume":"329","author":"G Yan","year":"2024","unstructured":"Yan G, Zhang L, Wu D, Jiang S, Wu Q, Dai M. Paeonol attenuates nonalcoholic steatohepatitis by regulating intestinal flora and AhR\/NLRP3\/Caspase-1 metabolic pathway. J Ethnopharmacol. 2024;329:118147. https:\/\/doi.org\/10.1016\/j.jep.2024.118147.","journal-title":"J Ethnopharmacol"},{"key":"554_CR73","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41577-019-0125-8","volume":"19","author":"V Rothhammer","year":"2019","unstructured":"Rothhammer V, Quintana FJ. The aryl hydrocarbon receptor: an environmental sensor integrating immune responses in health and disease. Nat Rev Immunol. 2019;19:184\u201397. https:\/\/doi.org\/10.1038\/s41577-019-0125-8.","journal-title":"Nat Rev Immunol"},{"key":"554_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114428","volume":"185","author":"Z Kou","year":"2021","unstructured":"Kou Z, Dai W. Aryl hydrocarbon receptor: its roles in physiology. Biochem Pharmacol. 2021;185:114428. https:\/\/doi.org\/10.1016\/j.bcp.2021.114428.","journal-title":"Biochem Pharmacol"},{"key":"554_CR75","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.celrep.2018.03.109","volume":"23","author":"S Krishnan","year":"2018","unstructured":"Krishnan S, Ding Y, Saedi N, Choi M, Sridharan GV, Sherr DH, et al. Gut microbiota-derived tryptophan metabolites modulate inflammatory response in hepatocytes and macrophages. Cell Rep. 2018;23:1099\u2013111. https:\/\/doi.org\/10.1016\/j.celrep.2018.03.109.","journal-title":"Cell Rep"},{"key":"554_CR76","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20133328","author":"N Kelley","year":"2019","unstructured":"Kelley N, Jeltema D, Duan Y, He Y. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20133328.","journal-title":"Int J Mol Sci"},{"key":"554_CR77","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/s2213-8587(24)00318-8","volume":"13","author":"N Stefan","year":"2025","unstructured":"Stefan N, Yki-J\u00e4rvinen H, Neuschwander-Tetri BA. Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment. Lancet Diabetes Endocrinol. 2025;13:134\u201348. https:\/\/doi.org\/10.1016\/s2213-8587(24)00318-8.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"554_CR78","doi-asserted-by":"publisher","DOI":"10.1136\/egastro-2025-100218","volume":"3","author":"Z Yang","year":"2025","unstructured":"Yang Z, Liu Z, Liu W, Dong XC. Steatotic liver disease and cancer: from pathogenesis to therapeutic targets. eGastroenterology. 2025;3:e100218. https:\/\/doi.org\/10.1136\/egastro-2025-100218.","journal-title":"eGastroenterology"},{"key":"554_CR79","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3892\/mmr.2014.2207","volume":"10","author":"XG Cai","year":"2014","unstructured":"Cai XG, Xia JR, Li WD, Lu FL, Liu J, Lu Q, et al. Anti-fibrotic effects of specific-siRNA targeting of the receptor for advanced glycation end products in a rat model of experimental hepatic fibrosis. Mol Med Rep. 2014;10:306\u201314. https:\/\/doi.org\/10.3892\/mmr.2014.2207.","journal-title":"Mol Med Rep"},{"key":"554_CR80","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/s2468-1253(17)30362-x","volume":"3","author":"B Hudson","year":"2018","unstructured":"Hudson B, Round J, Georgeson B, Pring A, Forbes K, McCune CA, et al. Cirrhosis with ascites in the last year of life: a nationwide analysis of factors shaping costs, health-care use, and place of death in England. Lancet Gastroenterol Hepatol. 2018;3:95\u2013103. https:\/\/doi.org\/10.1016\/s2468-1253(17)30362-x.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"554_CR81","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","volume":"18","author":"T Kisseleva","year":"2021","unstructured":"Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol. 2021;18:151\u201366. https:\/\/doi.org\/10.1038\/s41575-020-00372-7.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"554_CR82","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1111\/j.1478-3231.2008.01826.x","volume":"28","author":"OA Gressner","year":"2008","unstructured":"Gressner OA, Gressner AM. Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases. Liver Int. 2008;28:1065\u201379. https:\/\/doi.org\/10.1111\/j.1478-3231.2008.01826.x.","journal-title":"Liver Int"},{"key":"554_CR83","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1111\/jgh.12147","volume":"28","author":"D Kong","year":"2013","unstructured":"Kong D, Zhang F, Wei D, Zhu X, Zhang X, Chen L, et al. Paeonol inhibits hepatic fibrogenesis via disrupting nuclear factor-\u03baB pathway in activated stellate cells: in vivo and in vitro studies. J Gastroenterol Hepatol. 2013;28:1223\u201333. https:\/\/doi.org\/10.1111\/jgh.12147.","journal-title":"J Gastroenterol Hepatol"},{"key":"554_CR84","first-page":"1255","volume":"12","author":"D Kong","year":"2020","unstructured":"Kong D, Chen L, Huang W, Zhang Z, Wang L, Zhang F, et al. Combined therapy with ligustrazine and paeonol mitigates hepatic fibrosis through destroying mitochondrial integrity of stellate cell. Am J Transl Res. 2020;12:1255\u201366.","journal-title":"Am J Transl Res"},{"key":"554_CR85","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/s41588-022-01141-9","volume":"54","author":"D Barkley","year":"2022","unstructured":"Barkley D, Moncada R, Pour M, Liberman DA, Dryg I, Werba G, et al. Cancer cell states recur across tumor types and form specific interactions with the tumor microenvironment. Nat Genet. 2022;54:1192\u2013201. https:\/\/doi.org\/10.1038\/s41588-022-01141-9.","journal-title":"Nat Genet"},{"key":"554_CR86","first-page":"326","volume":"45","author":"Global cancer burden growing","year":"2024","unstructured":"Global cancer burden growing. amidst mounting need for services. Saudi Med J. 2024;45:326\u20137.","journal-title":"Saudi Med J"},{"key":"554_CR87","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/s0140-6736(18)30010-2","volume":"391","author":"A Forner","year":"2018","unstructured":"Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391:1301\u201314. https:\/\/doi.org\/10.1016\/s0140-6736(18)30010-2.","journal-title":"Lancet"},{"key":"554_CR88","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2021.12040","author":"SQ Sheng","year":"2021","unstructured":"Sheng SQ, Yu LY, Zhou XW, Pan HY, Hu FY, Liu JL. Paeonol prevents migration and invasion, and promotes apoptosis of cervical cancer cells by inhibiting 5-lipoxygenase. Mol Med Rep. 2021. https:\/\/doi.org\/10.3892\/mmr.2021.12040.","journal-title":"Mol Med Rep"},{"key":"554_CR89","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s12094-020-02455-y","volume":"23","author":"JJ Zhang","year":"2021","unstructured":"Zhang JJ, Cai LJ, Pang K, Dong Y, Zhang ZG, Li BB, et al. Paeonol inhibits proliferation and induces cell apoptosis of human T24 and 5637 bladder cancer cells in vitro and in vivo. Clin Transl Oncol. 2021;23:601\u201311. https:\/\/doi.org\/10.1007\/s12094-020-02455-y.","journal-title":"Clin Transl Oncol"},{"key":"554_CR90","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1002\/ddr.21873","volume":"83","author":"J Lv","year":"2022","unstructured":"Lv J, Zhu S, Chen H, Xu Y, Su Q, Yu G, et al. Paeonol inhibits human lung cancer cell viability and metastasis in vitro via miR-126-5p\/ZEB2 axis. Drug Dev Res. 2022;83:432\u201346. https:\/\/doi.org\/10.1002\/ddr.21873.","journal-title":"Drug Dev Res"},{"key":"554_CR91","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.ejphar.2008.02.016","volume":"584","author":"GP Sun","year":"2008","unstructured":"Sun GP, Wang H, Xu SP, Shen YX, Wu Q, Chen ZD, et al. Anti-tumor effects of paeonol in a HepA-hepatoma bearing mouse model via induction of tumor cell apoptosis and stimulation of IL-2 and TNF-\u03b1 production. Eur J Pharmacol. 2008;584:246\u201352. https:\/\/doi.org\/10.1016\/j.ejphar.2008.02.016.","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"554_CR92","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1111\/j.1745-7254.2007.00564.x","volume":"28","author":"SP Xu","year":"2007","unstructured":"Xu SP, Sun GP, Shen YX, Peng WR, Wang H. Synergistic effect of combining paeonol and cisplatin on apoptotic induction of human hepatoma cell lines. Acta Pharmacol Sin. 2007;28(6):869\u201378. https:\/\/doi.org\/10.1111\/j.1745-7254.2007.00564.x. (Wei W).","journal-title":"Acta Pharmacol Sin"},{"key":"554_CR93","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/CAD.0b013e3282f7f4eb","volume":"19","author":"Z Chunhu","year":"2008","unstructured":"Chunhu Z, Suiyu H, Meiqun C, Guilin X, Yunhui L. Antiproliferative and apoptotic effects of paeonol on human hepatocellular carcinoma cells. Anticancer Drugs. 2008;19:401\u20139. https:\/\/doi.org\/10.1097\/CAD.0b013e3282f7f4eb.","journal-title":"Anticancer Drugs"},{"key":"554_CR94","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-012288","author":"R Paredes","year":"2025","unstructured":"Paredes R, Borea R, Drago F, Russo A, Nigita G, Rolfo C. Genetic drivers of tumor microenvironment and immunotherapy resistance in non-small cell lung cancer: the role of KEAP1, SMARCA4, and PTEN mutations. J Immunother Cancer. 2025. https:\/\/doi.org\/10.1136\/jitc-2025-012288.","journal-title":"J Immunother Cancer"},{"key":"554_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.136455","volume":"281","author":"Y Wu","year":"2024","unstructured":"Wu Y, Guo X, Jin L, Huang G, Niu L, Zhao Y. Lnc-LINC00511 promotes gastric cancer progression by regulating MiR-29c-3p\/TRIP13 axis through AKT\/mTOR pathway. Int J Biol Macromol. 2024;281:136455. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.136455.","journal-title":"Int J Biol Macromol"},{"key":"554_CR96","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1124\/pharmrev.121.000349","volume":"74","author":"LGN de Almeida","year":"2022","unstructured":"de Almeida LGN, Thode H, Eslambolchi Y, Chopra S, Young D, Gill S, et al. Matrix metalloproteinases: from molecular mechanisms to physiology, pathophysiology, and pharmacology. Pharmacol Rev. 2022;74:712\u201368. https:\/\/doi.org\/10.1124\/pharmrev.121.000349.","journal-title":"Pharmacol Rev"},{"key":"554_CR97","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1111\/liv.15682","volume":"43","author":"PM Rodrigues","year":"2023","unstructured":"Rodrigues PM, Afonso MB, Sim\u00e3o AL, Islam T, Gaspar MM, O\u2019Rourke CJ, et al. Mir-21-5p promotes NASH-related hepatocarcinogenesis. Liver Int. 2023;43:2256\u201374. https:\/\/doi.org\/10.1111\/liv.15682.","journal-title":"Liver Int"},{"key":"554_CR98","doi-asserted-by":"publisher","first-page":"4653","DOI":"10.1038\/onc.2016.2","volume":"35","author":"LG Ahronian","year":"2016","unstructured":"Ahronian LG, Zhu LJ, Chen YW, Chu HC, Klimstra DS, Lewis BC. A novel KLF6-Rho GTPase axis regulates hepatocellular carcinoma cell migration and dissemination. Oncogene. 2016;35:4653\u201362. https:\/\/doi.org\/10.1038\/onc.2016.2.","journal-title":"Oncogene"},{"issue":"4","key":"554_CR99","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jhep.2006.10.012","volume":"46","author":"S Kremer-Tal","year":"2007","unstructured":"Kremer-Tal S, Narla G, Chen Y, Hod E, DiFeo A, Yea S, et al. Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiation. J Hepatol. 2007;46(4):645\u201354. https:\/\/doi.org\/10.1016\/j.jhep.2006.10.012.","journal-title":"J Hepatol"},{"key":"554_CR100","doi-asserted-by":"publisher","first-page":"5931","DOI":"10.2147\/cmar.S254485","volume":"12","author":"M Cai","year":"2020","unstructured":"Cai M, Shao W, Yu H, Hong Y, Shi L. Paeonol inhibits cell proliferation, migration and invasion and induces apoptosis in hepatocellular carcinoma by regulating miR-21-5p\/KLF6 axis. Cancer Manag Res. 2020;12:5931\u201343. https:\/\/doi.org\/10.2147\/cmar.S254485.","journal-title":"Cancer Manag Res"},{"key":"554_CR101","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.3109\/09553002.2013.825058","volume":"89","author":"Y Lei","year":"2013","unstructured":"Lei Y, Li HX, Jin WS, Peng WR, Zhang CJ, Bu LJ, et al. The radiosensitizing effect of Paeonol on lung adenocarcinoma by augmentation of radiation-induced apoptosis and inhibition of the PI3K\/Akt pathway. Int J Radiat Biol. 2013;89:1079\u201386. https:\/\/doi.org\/10.3109\/09553002.2013.825058.","journal-title":"Int J Radiat Biol"},{"key":"554_CR102","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.acthis.2013.04.004","volume":"115","author":"J Yin","year":"2013","unstructured":"Yin J, Wu N, Zeng F, Cheng C, Kang K, Yang H. Paeonol induces apoptosis in human ovarian cancer cells. Acta Histochem. 2013;115:835\u20139. https:\/\/doi.org\/10.1016\/j.acthis.2013.04.004.","journal-title":"Acta Histochem"},{"key":"554_CR103","doi-asserted-by":"publisher","first-page":"5444","DOI":"10.1182\/blood-2009-01-201335","volume":"113","author":"J Hoggatt","year":"2009","unstructured":"Hoggatt J, Singh P, Sampath J, Pelus LM. Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation. Blood. 2009;113:5444\u201355. https:\/\/doi.org\/10.1182\/blood-2009-01-201335.","journal-title":"Blood"},{"key":"554_CR104","doi-asserted-by":"publisher","first-page":"7183","DOI":"10.21037\/tcr-20-322A","volume":"9","author":"H Liu","year":"2020","unstructured":"Liu H, Zhang C. Paeonol induces antitumor effects in hepatocellular carcinoma cells through survivin via the cyclooxygenase-2\/prostaglandin E2 signaling pathway. Transl Cancer Res. 2020;9:7183\u201395. https:\/\/doi.org\/10.21037\/tcr-20-322A.","journal-title":"Transl Cancer Res"},{"key":"554_CR105","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19113534","author":"Y Yan","year":"2018","unstructured":"Yan Y, Zhou XE, Xu HE, Melcher K. Structure and physiological regulation of AMPK. Int J Mol Sci. 2018. https:\/\/doi.org\/10.3390\/ijms19113534.","journal-title":"Int J Mol Sci"},{"key":"554_CR106","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9895121","volume":"2020","author":"BT Assefa","year":"2020","unstructured":"Assefa BT, Tafere GG, Wondafrash DZ, Gidey MT. The bewildering effect of AMPK activators in Alzheimer\u2019s disease: review of the current evidence. Biomed Res Int. 2020;2020:9895121. https:\/\/doi.org\/10.1155\/2020\/9895121.","journal-title":"Biomed Res Int"},{"key":"554_CR107","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.1016\/j.apsb.2025.05.015","volume":"15","author":"J Li","year":"2025","unstructured":"Li J, Wang M, Qu K, Sun Y, Yin Z, Dong N, et al. IMM-H007 promotes hepatic cholesterol and triglyceride metabolism by activating AMPK\u03b1 to attenuate hypercholesterolemia. Acta Pharm Sin B. 2025;15:4047\u201363. https:\/\/doi.org\/10.1016\/j.apsb.2025.05.015.","journal-title":"Acta Pharm Sin B"},{"key":"554_CR108","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-025-03477-6","volume":"44","author":"J Liu","year":"2025","unstructured":"Liu J, Zhang X, Fan X, Liu P, Mi Z, Tan H, et al. Liensinine reshapes the immune microenvironment and enhances immunotherapy by reprogramming metabolism through the AMPK-HIF-1\u03b1 axis in hepatocellular carcinoma. J Exp Clin Cancer Res. 2025;44:208. https:\/\/doi.org\/10.1186\/s13046-025-03477-6.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"554_CR109","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.apsb.2024.10.010","volume":"15","author":"A Zhuge","year":"2025","unstructured":"Zhuge A, Li S, Han S, Yuan Y, Shen J, Wu W, et al. Akkermansia muciniphila-derived acetate activates the hepatic AMPK\/SIRT1\/PGC-1\u03b1 axis to alleviate ferroptosis in metabolic-associated fatty liver disease. Acta Pharm Sin B. 2025;15(1):151\u201367. https:\/\/doi.org\/10.1016\/j.apsb.2024.10.010.","journal-title":"Acta Pharm Sin B"},{"key":"554_CR110","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.chmed.2021.09.015","volume":"14","author":"S Wen","year":"2022","unstructured":"Wen S, An R, Li D, Cao J, Li Z, Zhang W, et al. Tea and Citrus maxima complex induces apoptosis of human liver cancer cells via PI3K\/AKT\/mTOR pathway in vitro. Chin Herbal Med. 2022;14:449\u201358. https:\/\/doi.org\/10.1016\/j.chmed.2021.09.015.","journal-title":"Chin Herbal Med"},{"key":"554_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.119890","volume":"348","author":"WF Cai","year":"2025","unstructured":"Cai WF, Chen QC, Ni Q, Liu L, Liu Q, Yi YK, et al. P-synephrine ameliorates non-alcoholic fatty liver disease by regulating liver-adipose axis via AMPK\/NF-kappa b pathway. J Ethnopharmacol. 2025;348:119890. https:\/\/doi.org\/10.1016\/j.jep.2025.119890.","journal-title":"J Ethnopharmacol"},{"key":"554_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.120108","volume":"351","author":"LJ Zhang","year":"2025","unstructured":"Zhang LJ, Li SY, Fan SL, Nuerbiye A, Zhao JY, Keremu B, et al. Hepatoprotective activity of mulberry extract in NAFLD mice for regulating lipid metabolism and inflammation identified via AMPK\/PPAR-\u03b3\/NF-\u03baB axis. J Ethnopharmacol. 2025;351:120108. https:\/\/doi.org\/10.1016\/j.jep.2025.120108.","journal-title":"J Ethnopharmacol"},{"key":"554_CR113","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.7150\/ijbs.89942","volume":"20","author":"F Fontana","year":"2024","unstructured":"Fontana F, Giannitti G, Marchesi S, Limonta P. The PI3K\/Akt pathway and glucose metabolism: a dangerous liaison in cancer. Int J Biol Sci. 2024;20:3113\u201325. https:\/\/doi.org\/10.7150\/ijbs.89942.","journal-title":"Int J Biol Sci"},{"key":"554_CR114","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1172\/jci11891","volume":"107","author":"AS Baldwin Jr.","year":"2001","unstructured":"Baldwin AS Jr. Series introduction: the transcription factor NF-kappaB and human disease. J Clin Invest. 2001;107:3\u20136. https:\/\/doi.org\/10.1172\/jci11891.","journal-title":"J Clin Invest"},{"key":"554_CR115","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1126\/science.281.5383.1680","volume":"281","author":"CY Wang","year":"1998","unstructured":"Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS Jr. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science. 1998;281:1680\u20133. https:\/\/doi.org\/10.1126\/science.281.5383.1680.","journal-title":"Science"},{"key":"554_CR116","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1093\/annonc\/mdf337","volume":"13","author":"Y Xu","year":"2002","unstructured":"Xu Y, Villalona-Calero MA. Irinotecan: mechanisms of tumor resistance and novel strategies for modulating its activity. Ann Oncol. 2002;13:1841\u201351. https:\/\/doi.org\/10.1093\/annonc\/mdf337.","journal-title":"Ann Oncol"},{"key":"554_CR117","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/j.1742-481X.2011.00771.x","volume":"8","author":"RL Chalmers","year":"2011","unstructured":"Chalmers RL. The evidence for the role of transforming growth factor-beta in the formation of abnormal scarring. Int Wound J. 2011;8:218\u201323. https:\/\/doi.org\/10.1111\/j.1742-481X.2011.00771.x.","journal-title":"Int Wound J"},{"key":"554_CR118","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cbi.2018.07.008","volume":"292","author":"HH Hu","year":"2018","unstructured":"Hu HH, Chen DQ, Wang YN, Feng YL, Cao G, Vaziri ND, et al. New insights into TGF-\u03b2\/Smad signaling in tissue fibrosis. Chem Biol Interact. 2018;292:76\u201383. https:\/\/doi.org\/10.1016\/j.cbi.2018.07.008.","journal-title":"Chem Biol Interact"},{"key":"554_CR119","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jdermsci.2003.12.006","volume":"35","author":"M Schiller","year":"2004","unstructured":"Schiller M, Javelaud D, Mauviel A. TGF-\u03b2-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing. J Dermatol Sci. 2004;35:83\u201392. https:\/\/doi.org\/10.1016\/j.jdermsci.2003.12.006.","journal-title":"J Dermatol Sci"},{"key":"554_CR120","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/nm.2807","volume":"18","author":"TA Wynn","year":"2012","unstructured":"Wynn TA, Ramalingam TR. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med. 2012;18:1028\u201340. https:\/\/doi.org\/10.1038\/nm.2807.","journal-title":"Nat Med"},{"issue":"1","key":"554_CR121","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/cr.2010.183","volume":"21","author":"G He","year":"2011","unstructured":"He G, Karin M. NF-\u03baB and STAT3\u2014key players in liver inflammation and cancer. Cell Res. 2011;21(1):159\u201368. https:\/\/doi.org\/10.1038\/cr.2010.183.","journal-title":"Cell Res"},{"key":"554_CR122","doi-asserted-by":"publisher","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun SC. NF-\u03baB signaling in inflammation. Signal Transduct Target Ther. 2017;2:17023. https:\/\/doi.org\/10.1038\/sigtrans.2017.23.","journal-title":"Signal Transduct Target Ther"},{"key":"554_CR123","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/s41423-025-01310-w","volume":"22","author":"H Mao","year":"2025","unstructured":"Mao H, Zhao X, Sun SC. NF-\u03baB in inflammation and cancer. Cell Mol Immunol. 2025;22:811\u201339. https:\/\/doi.org\/10.1038\/s41423-025-01310-w.","journal-title":"Cell Mol Immunol"},{"key":"554_CR124","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01757-9","volume":"9","author":"Q Guo","year":"2024","unstructured":"Guo Q, Jin Y, Chen X, Ye X, Shen X, Lin M, et al. NF-\u03baB in biology and targeted therapy: new insights and translational implications. Signal Transduct Target Ther. 2024;9:53. https:\/\/doi.org\/10.1038\/s41392-024-01757-9.","journal-title":"Signal Transduct Target Ther"},{"key":"554_CR125","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/ni.1863","volume":"11","author":"T Kawai","year":"2010","unstructured":"Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 2010;11:373\u201384. https:\/\/doi.org\/10.1038\/ni.1863.","journal-title":"Nat Immunol"},{"key":"554_CR126","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/ni1116","volume":"5","author":"DN Cook","year":"2004","unstructured":"Cook DN, Pisetsky DS, Schwartz DA. Toll-like receptors in the pathogenesis of human disease. Nat Immunol. 2004;5:975\u20139. https:\/\/doi.org\/10.1038\/ni1116.","journal-title":"Nat Immunol"},{"key":"554_CR127","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.3892\/ol.2018.9730","volume":"17","author":"Q Li","year":"2019","unstructured":"Li Q, Zhang Y, Sun J, Bo Q. Paeonol-mediated apoptosis of hepatocellular carcinoma cells by NF-\u03baB pathway. Oncol Lett. 2019;17:1761\u20137. https:\/\/doi.org\/10.3892\/ol.2018.9730.","journal-title":"Oncol Lett"},{"key":"554_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154627","volume":"110","author":"Z Lin","year":"2023","unstructured":"Lin Z, Liao L, Zhao S, Gu W, Wang G, Shen Z, et al. Corylin inhibits the progression of non-small cell lung cancer cells by regulating NF-\u03baB signaling pathway via targeting p65. Phytomedicine. 2023;110:154627. https:\/\/doi.org\/10.1016\/j.phymed.2022.154627.","journal-title":"Phytomedicine"},{"key":"554_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154307","volume":"104","author":"L Jin","year":"2022","unstructured":"Jin L, Guo Y, Mao W, Wang J, Jin L, Liu X, et al. Total glucosides of paeony inhibit breast cancer growth by inhibiting TAMs infiltration through NF-\u03baB\/CCL2 signaling. Phytomedicine. 2022;104:154307. https:\/\/doi.org\/10.1016\/j.phymed.2022.154307.","journal-title":"Phytomedicine"},{"key":"554_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117544","volume":"250","author":"KM Adki","year":"2020","unstructured":"Adki KM, Kulkarni YA. Chemistry, pharmacokinetics, pharmacology and recent novel drug delivery systems of paeonol. Life Sci. 2020;250:117544. https:\/\/doi.org\/10.1016\/j.lfs.2020.117544.","journal-title":"Life Sci"},{"key":"554_CR131","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-019-0282-2","volume":"9","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Liu Y, Liu H, Tang WH. Exosomes: biogenesis, biologic function and clinical potential. Cell Biosci. 2019;9:19. https:\/\/doi.org\/10.1186\/s13578-019-0282-2.","journal-title":"Cell Biosci"},{"key":"554_CR132","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.actbio.2018.12.045","volume":"86","author":"W Liao","year":"2019","unstructured":"Liao W, Du Y, Zhang C, Pan F, Yao Y, Zhang T, et al. Exosomes: The next generation of endogenous nanomaterials for advanced drug delivery and therapy. Acta Biomater. 2019;86:1\u201314. https:\/\/doi.org\/10.1016\/j.actbio.2018.12.045.","journal-title":"Acta Biomater"},{"key":"554_CR133","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/978-3-030-67171-6_14","volume":"97","author":"C Nedeva","year":"2021","unstructured":"Nedeva C, Mathivanan S. Engineering extracellular vesicles for cancer therapy. Sub-cellular Biochem. 2021;97:375\u201392. https:\/\/doi.org\/10.1007\/978-3-030-67171-6_14.","journal-title":"Sub-cellular Biochem"},{"key":"554_CR134","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1016\/j.bioactmat.2021.01.009","volume":"6","author":"B Adriano","year":"2021","unstructured":"Adriano B, Cotto NM, Chauhan N, Jaggi M, Chauhan SC, Yallapu MM. Milk exosomes: nature\u2019s abundant nanoplatform for theranostic applications. Bioact Mater. 2021;6:2479\u201390. https:\/\/doi.org\/10.1016\/j.bioactmat.2021.01.009.","journal-title":"Bioact Mater"},{"key":"554_CR135","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/aps.2017.12","volume":"38","author":"X Luan","year":"2017","unstructured":"Luan X, Sansanaphongpricha K, Myers I, Chen H, Yuan H, Sun D. Engineering exosomes as refined biological nanoplatforms for drug delivery. Acta Pharmacol Sin. 2017;38:754\u201363. https:\/\/doi.org\/10.1038\/aps.2017.12.","journal-title":"Acta Pharmacol Sin"},{"key":"554_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116381","volume":"173","author":"V Albaladejo-Garc\u00eda","year":"2024","unstructured":"Albaladejo-Garc\u00eda V, Mor\u00e1n L, Santos-Coquillat A, Gonz\u00e1lez MI, Ye H, V\u00e1zquez Ogando E, et al. Curcumin encapsulated in milk small extracellular vesicles as a nanotherapeutic alternative in experimental chronic liver disease. Biomed Pharmacother. 2024;173:116381. https:\/\/doi.org\/10.1016\/j.biopha.2024.116381.","journal-title":"Biomed Pharmacother"},{"key":"554_CR137","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/nrc.2016.89","volume":"16","author":"F R\u00f6hrig","year":"2016","unstructured":"R\u00f6hrig F, Schulze A. The multifaceted roles of fatty acid synthesis in cancer. Nat Rev Cancer. 2016;16:732\u201349. https:\/\/doi.org\/10.1038\/nrc.2016.89.","journal-title":"Nat Rev Cancer"},{"key":"554_CR138","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1080\/15384101.2017.1282586","volume":"16","author":"L Che","year":"2017","unstructured":"Che L, Pilo MG, Cigliano A, Latte G, Simile MM, Ribback S, et al. Oncogene dependent requirement of fatty acid synthase in hepatocellular carcinoma. Cell Cycle. 2017;16:499\u2013507. https:\/\/doi.org\/10.1080\/15384101.2017.1282586.","journal-title":"Cell Cycle"},{"key":"554_CR139","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1053\/j.gastro.2010.12.006","volume":"140","author":"DF Calvisi","year":"2011","unstructured":"Calvisi DF, Wang C, Ho C, Ladu S, Lee SA, Mattu S, et al. Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma. Gastroenterology. 2011;140:1071\u201383. https:\/\/doi.org\/10.1053\/j.gastro.2010.12.006.","journal-title":"Gastroenterology"},{"key":"554_CR140","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1136\/gutjnl-2018-317581","volume":"69","author":"L Che","year":"2020","unstructured":"Che L, Chi W, Qiao Y, Zhang J, Song X, Liu Y, et al. Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans. Gut. 2020;69:177\u201386. https:\/\/doi.org\/10.1136\/gutjnl-2018-317581.","journal-title":"Gut"},{"key":"554_CR141","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1021\/jacs.4c11930","volume":"147","author":"Y Liu","year":"2025","unstructured":"Liu Y, Sun X, Liu Q, Han C, Rao Y. A dual-target and dual-mechanism design strategy by combining inhibition and degradation together. J Am Chem Soc. 2025;147:3110\u20138. https:\/\/doi.org\/10.1021\/jacs.4c11930.","journal-title":"J Am Chem Soc"},{"key":"554_CR142","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.270","volume":"4","author":"X Lin","year":"2025","unstructured":"Lin X, Yu Z, Liu Y, Li C, Hu H, Hu JC, et al. Gut-X axis. iMeta. 2025;4:e270. https:\/\/doi.org\/10.1002\/imt2.270.","journal-title":"iMeta"},{"key":"554_CR143","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1038\/s42255-025-01356-0","volume":"7","author":"S Jung","year":"2025","unstructured":"Jung S, Bae H, Song WS, Chun Y, Le J, Alam Y, et al. Dietary fibre-adapted gut microbiome clears dietary fructose and reverses hepatic steatosis. Nat Metab. 2025;7:1801\u201318. https:\/\/doi.org\/10.1038\/s42255-025-01356-0.","journal-title":"Nat Metab"},{"key":"554_CR144","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.chom.2025.04.011","volume":"33","author":"Y Zeng","year":"2025","unstructured":"Zeng Y, Wu R, He Y, Zhang Q, Wang Z, Qin P, et al. Cohabitation facilitates microbiome shifts that promote isoflavone transformation to ameliorate liver injury. Cell Host Microbe. 2025;33:688\u2013704. https:\/\/doi.org\/10.1016\/j.chom.2025.04.011.","journal-title":"Cell Host Microbe"},{"key":"554_CR145","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1016\/j.cmet.2025.07.001","volume":"37","author":"H Fang","year":"2025","unstructured":"Fang H, Anh\u00ea FF, Zada DK, Barra NG, McAlpin BT, Wylie R, et al. Gut substrate trap of D-lactate from microbiota improves blood glucose and fatty liver disease in obese mice. Cell Metab. 2025;37:1806\u201319. https:\/\/doi.org\/10.1016\/j.cmet.2025.07.001.","journal-title":"Cell Metab"},{"key":"554_CR146","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/hep.0000000000000985","volume":"82","author":"S Hai","year":"2025","unstructured":"Hai S, Li X, Xie E, Wu W, Gao Q, Yu B, et al. Intestinal IL-33 promotes microbiota-derived trimethylamine N -oxide synthesis and drives metabolic dysfunction-associated steatotic liver disease progression by exerting dual regulation on HIF-1\u03b1. Hepatology. 2025;82:184\u201398. https:\/\/doi.org\/10.1097\/hep.0000000000000985.","journal-title":"Hepatology"},{"key":"554_CR147","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1038\/s42255-025-01318-6","volume":"7","author":"H Kim","year":"2025","unstructured":"Kim H, Nelson P, Nzabarushimana E, Shen J, Jensen J, Bhosle A, et al. Multi-omic analysis reveals transkingdom gut dysbiosis in metabolic dysfunction-associated steatotic liver disease. Nat Metab. 2025;7:1476\u201392. https:\/\/doi.org\/10.1038\/s42255-025-01318-6.","journal-title":"Nat Metab"}],"container-title":["Natural Products and Bioprospecting"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13659-025-00554-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13659-025-00554-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13659-025-00554-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T23:05:44Z","timestamp":1767654344000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13659-025-00554-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":147,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["554"],"URL":"https:\/\/doi.org\/10.1007\/s13659-025-00554-3","relation":{"references":[{"id-type":"doi","id":"10.3390\/foods14040604","asserted-by":"subject"}]},"ISSN":["2192-2195","2192-2209"],"issn-type":[{"value":"2192-2195","type":"print"},{"value":"2192-2209","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,6]]},"assertion":[{"value":"1 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2"}}